Form 4: CME Group Chief Transformation Officer Ken Vroman Reports Stock Transactions

Ken Vroman, Chief Transformation Officer of CME Group, reports the acquisition and disposal of company stock related to tax obligations and stock awards.

Summary

• On September 15, 2024, Ken Vroman surrendered 1,292 shares of CME Group Class A common stock to cover tax obligations at a price of $216.99 per share.
• Following this transaction, Mr. Vroman directly owned 18,693 shares.
• On September 16, 2024, Mr. Vroman acquired 3,088 shares of CME Group Class A common stock at a price of $218.53 per share.
• After this acquisition, Mr. Vroman's direct ownership increased to 21,781 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing primarily reports stock transactions related to compensation and tax obligations. There is no indication of positive or negative sentiment towards the company's performance.

Positives

• The acquisition of 3,088 shares suggests confidence in CME Group's future performance.

Future Outlook

The document does not contain specific forward-looking statements about CME Group's future performance.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.

Comparison to Industry Standards

• Executive stock transactions are a common occurrence in publicly traded companies like CME Group.
• Similar filings are made by executives at competitors such as Intercontinental Exchange (ICE) and Nasdaq, Inc. (NDAQ).
• The size and frequency of these transactions are typical for executives receiving stock-based compensation.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
• The increased ownership by a key executive could be viewed positively by shareholders.

Key Dates